Inhibikase Therapeutics, Inc. Common Stock IKT

$2.41 +0.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-11 View →
8-K 8-K 2026-08-11 View →
4 Insider transaction 2026-07-31 View →
4 4 2026-07-31 View →
8-K 8-K 2026-07-29 View →
8-K 8-K 2026-07-23 View →
8-K 8-K 2026-07-14 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
4 4 2026-06-30 View →
8-K 8-K 2026-06-29 View →
10-Q 10-Q 2026-05-12 View →
8-K 8-K 2026-05-12 View →
DEF 14A DEF 14A 2026-04-30 View →
8-K 8-K 2026-04-07 View →
10-K 10-K 2026-03-26 View →
8-K 8-K 2026-03-26 View →
4 4 2026-02-24 View →
4 4 2026-02-24 View →
4 4 2026-02-24 View →
4 4 2026-01-07 View →
4 4 2026-01-07 View →
4 4 2026-01-07 View →
8-K 8-K 2025-12-19 View →
424B5 424B5 2025-12-19 View →
4 PRIMARY DOCUMENT 2025-11-24 View →
8-K 8-K 2025-11-21 View →
424B5 424B5 2025-11-21 View →
424B5 424B5 2025-11-20 View →
8-K 8-K 2025-11-20 View →
10-Q 10-Q 2025-11-14 View →
8-K 8-K 2025-11-14 View →
4 4 2025-08-28 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-08-14 View →
4 4 2025-07-02 View →
4 4 2025-07-02 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.41
Market Cap
$336.28 million
52-Week Range
$1.33 – $2.53
Average Volume
860K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.